WPRIM Management System> DCMS> Korean Journal of Psychopharmacology> 2007> 18

Volume: 18

1. Hyponatremia with Neurological Symptom in Patients with Chronic Schizophrenia : Five Cases. Page:110—117
2. Body Mass Index(BMI) Changes during Combination Therapy with Mood Stabilizers and Antipsychotics in Acute Mania. Page:103—109
3. Body Weight Gain and Metabolic Changes in Patients with Schizophrenia during 12-Week Randomized Treatment of Ziprasidone and Risperidone. Page:92—102
4. Two-Year Rehospitalization Rates of First Episode Schizophrenic Inpatients Discharged on Antipsychotic Medication : A Preliminary Study. Page:86—91
5. Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia. Page:81—85
6. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(II): Initial Treatment and Treatment Resistant OCD. Page:347—357
7. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007 (I). Page:338—346
8. Maintenance Period of Venlafaxine ER Treatment in Patients Having Major Depressive Disorder with Somatic Symptoms. Page:329—337
9. Risperidone Combination in the Acute Treatment of Bipolar Mania and Mixed Episode: Prospective, Multicenter, Open Trial. Page:318—328
10. A Case of Single Photon Emission Computerized Tomographic Finding in Patient with Acquired Deafness and Musical Hallucinosis after Viral Encephalitis. Page:60—64
11. Prescription Status and Efficacy of OROS-MPH and Parent Perception in Children with Attention Deficit Hyperactivity Disorder : Multi-Center, Observational Study during 4 Weeks. Page:50—59
12. Multicenter Clinical Trials for Efficacy and Safety of Mirtazapine in Moderate-to-Severe Major Depressive Patients. Page:36—49
13. Do SSRIs Really Induce Suicidal Behavior? : The Critical Review of Evidences. Page:25—35
14. Intravenous Anti-obsessive Agents : A Review. Page:18—24
15. Korean Traditional Medicines as Novel Drugs for Neuropsychiatric Disorders. Page:5—17
16. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium. Page:423—428
17. Comparison of the Clinical Efficacy and Safety between Intramuscular Olanzapine and Intramuscular Haloperidol Injection in the Treatment of Delirium. Page:423—428
18. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions. Page:414—422
19. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(IV): Comorbid Conditions. Page:414—422
20. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy. Page:408—413
21. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007(III): A Preliminary Study for Application of Cognitive-Behavioral Therapy. Page:408—413
22. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006. Page:399—407
23. Changes of Medication Usage in Inpatients with Major Depressive Disorder: One University Hospital between Year 2001 and 2006. Page:399—407
24. The Association between Smoking and Depression. Page:393—398
25. The Association between Smoking and Depression. Page:393—398
26. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment. Page:384—392
27. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology. Page:373—383
28. Atypical Antipsychotics in Bipolar Depression: Neurobiological Mechanisms and Application to Treatment. Page:384—392
29. The Implication of Incrementally Modified Drug Technology and the Current Trends in Psychopharmacology. Page:373—383
30. Ziprasidone Induced Neutropenia. Page:251—255
31. Elevation of Serum Creatine Kinase Level in a Patient Treated with Atypical Antipsychotics: A Case Report. Page:246—250
32. Comparison of Efficacy between Aripiprazole and Haloperidol in the Treatment of Patients with Delirium. Page:240—245
33. Remission Rates and Criteria for Clinical Studies on Schizophrenia. Page:231—239
34. A Validation Study of the Korean Version of the Subjective Well-being Under Neuroleptic Treatment Scale-Short Form. Page:221—230
35. Common Gene Expression Pattern in the Rat Brain Induced by Several Mood: Stabilizing Drugs. Page:211—220
36. Brain Mapping for Memory and Learning. Page:199—210
37. Recent 5-Year Trends of Prescription Patterns in Inpatients with Bipolar Disorder in Four Hospitals. Page:308—317
38. The Relationship between the Antipsychotics-Induced Weight Gain and the Dopamine D2, D3, and D4 Receptor Gene Polymorphisms in Korean Schizophrenic Patients. Page:299—307
39. Effects of Haloperidol on Ca2+i Change in HIT T-15 Insulinoma Cells. Page:288—298
40. Neurokinin and Its Receptors: Association with Learning and Memory. Page:280—287
41. Role of 5-HT1A Receptors in Learning and Memory. Page:271—279
42. Rhabdomyolysis Associated with Ziprasidone. Page:181—184
43. Treatment of Persistent Hiccups with Risperidone Quicklet. Page:177—180
44. A Case of Aggressive and Violent Patient with Treatment-Resistant Schizophrenia Treated with Long-Acting Injectable Risperidone. Page:171—176
45. Clinical Efficacy and Safety of Memantine in Patients with Moderate to Severe Dementia. Page:163—170
46. The Subjective Effect of Quetiapine Monotherapy on Sleep and Daytime Sleepiness in Acute Manic Patient. Page:152—162
47. Association of BDNF Val66Met Polymorphism with Depressive and Cognitive Symptoms in Patients with Schizophrenia. Page:143—151
48. Neuroanatomy of Sleep-Wake Regulation and its Application to Pharmacotherapy. Page:133—142